How Liquid Biopsies Can Improve Brain Tumor Diagnoses

Brian Nahed, MD, MSc, associate director of the Mass General Neurosurgery Program, and Shannon Stott, PhD, assistant in genetics at Mass General, have developed a blood-based assay called liquid biopsy. This non-invasive procedure allows physicians to monitor a patient's tumor during treatment. They believe this collaborative research will improve the safety and efficacy of brain tumor treatment. Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital. Subscribe: https://pages.connect.massgeneral.org...